05 Jan, 2024, 09:25 ET
- UpDoc is the world’s first clinically validated, clinician-directed AI that manages medications and chronic conditions
- Strategic funding round led by Polaris Partners with participation from Mayo Clinic, Oxeon Partners, and Eli Lilly & Company
- Partnerships with Microsoft, Google Cloud, SCCIPA with research conducted at Stanford Medicine
- Strategic collaborations with UCSF Health will focus on improving health equity and with the American Heart Association will leverage expertise as a member of the American Heart Association Innovator’s Network
- UpDoc ushers in a new model of care delivery – Remote Patient Intervention (RPI) – that aims to deliver a clinician-directed AI provider to every patient’s home and bridge gaps in health equity
PALO ALTO, Calif., Jan. 5, 2024 /PRNewswire/ — UpDoc, the first company with a conversational AI platform that manages medication prescriptions, today exited stealth to announce a strategic funding round led by Polaris Partners with participation from Oxeon Partners, Eli Lilly & Company and Mayo Clinic. This follows landmark research conducted at Stanford Medicine and paves the way for additional collaborations with Microsoft, Google, Santa Clara County Independent Physician Association (SCCIPA), UCSF Health, Mayo Clinic, and the American Heart Association. UpDoc aims to deliver a clinician-directed AI provider to every patient’s home through accessible technology that improves access to high quality, affordable care. All care delivered through the AI is prescribed by physicians or clinical pharmacists who oversee the platform.
SOURCE: PRESS RELEASE; PRNEWSWIRE; UPDOC; https://www.prnewswire.com/news-releases/updoc-debuts-the-worlds-first-ai-assistant-that-manages-medication-prescriptions-and-chronic-conditions-302027175.html
Discover more from Concierge Medicine Today
Subscribe to get the latest posts sent to your email.
Categories: National Headlines
